2.43
0.17 (7.52%)
0.17 (7.52%)
Upgrade to Real-Time
Afterhours (Closed)
Low
1.74
High
6.83
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Genocea Biosciences Inc | GNCA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.17 | 7.52% | 2.43 | 17:52:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.28 | 2.27 | 2.47 | 2.43 | 2.26 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.40 | 2.48 | 0.08 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,325 | 412,044 | $ 2.36 | $ 974,477 | 602,384 | 1.74 - 6.83 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:46:10 | 1 | $ 2.46 | USD |
Genocea Biosciences Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 125.47M | 51.64M | 40.98M | $ - | $ - | -2.19 | -2.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Genocea Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GNCA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.51 | 2.55 | 2.02 | 2.20 | 252,027 | -0.08 | -3.19% |
| 1 Month | 2.59 | 2.87 | 2.02 | 2.50 | 291,563 | -0.16 | -6.18% |
| 3 Months | 2.9198 | 4.045 | 2.02 | 3.09 | 489,623 | -0.4898 | -16.78% |
| 6 Months | 2.27 | 4.045 | 1.80 | 2.80 | 470,239 | 0.16 | 7.05% |
| 1 Year | 1.95 | 6.83 | 1.74 | 3.07 | 616,586 | 0.48 | 24.62% |
| 3 Years | 0.8557 | 12.22 | 0.28 | 2.56 | 476,066 | 1.57 | 183.98% |
| 5 Years | 5.42 | 12.22 | 0.28 | 2.67 | 519,263 | -2.99 | -55.17% |
Genocea Biosciences Description
| Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines. |
